INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Grant or awardVerified data
HM

Hollywood Mark reported ZYME

EVP & Chief Operating Officer · Zymeworks Inc. · Common Stock

Side
A
Value
$21K
Shares
939
Price
$22.22
Executed
Jul 6, 2026
Disclosed
Jul 6, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jul 6 executedJul 6, 2026 disclosed

ZYME · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

    $21K reported value · 0.7% of prior position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ZYME

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    SA
    Schayowitz AdamEVP, Head of R&D
    ZYMEZymeworks Inc.
    Option exercise
    M—
    37.0K sh
    Oct 9, 2026Oct 9, 2026
    traded Oct 9, 2026
    +0dSEC FORM 4

    Evidence

    35
    SA
    Schayowitz AdamEVP, Head of R&D
    ZYMEZymeworks Inc.
    Open-market sale
    SELL$358K
    13.8K sh
    Oct 9, 2026Oct 9, 2026
    traded Oct 9, 2026
    +0dSEC FORM 4

    Evidence

    21
    SA
    Schayowitz AdamEVP, Head of R&D
    ZYMEZymeworks Inc.
    Option exercise
    M—
    37.0K sh
    Oct 9, 2026Oct 9, 2026
    traded Oct 9, 2026
    +0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002104446-26-000009
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jul 6, 2026
    Published
    Jul 6, 2026
    Ingested by INSIDER
    Nov 5, 03:49 UTC
    Last re-read
    Nov 5, 03:49 UTC

    Extracted facts

    Filer
    Hollywood Mark
    Role
    EVP & Chief Operating Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Zymeworks Inc.
    Ticker
    ZYME
    Shares
    939
    Price per share
    $22.22
    Value
    $20,865
    Execution date (reported)
    Jul 6, 2026
    Owned after transaction
    133.9K shares
    Days from execution to publication
    0

    Calculation

    Value = shares × reported price per share

    • Shares: 939
    • Price: $22.22

    = $20,865

    What this establishes

    Hollywood Mark filed this Form 4 reporting a grant or award of ZYME on Jul 6, 2026. It became public on Jul 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP & Chief Operating Officer
    Hollywood Markcik:0002104446
    Issuer
    Zymeworks Inc.cik:0001937653

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.